Links

When Interest Rates Go Low, Should Public Debt Go High?ROI for SDOH interventions.Consumption responses to sweetened beverage taxes.Do health care quality improvement policies work for all?“Provider respondents reported spending time equivalent of more than 100 000 full-time registered nurses per year on prior authorization. ”

Read More

Medicaid Postpartum Coverage Extension Tracker

This page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.

Read More

Act now for health coverage in 2025

Open Enrollment is now. Start 2025 off right by enrolling in coverage for the new year.  Image For coverage to start: January 1, 2025: Act by December 15, 2024February 1, 2025: Act by January 15, 2025 Make time today for a few easy steps. Coverage may be more affordable and easier than you think.  Apply…

Read More

How come I owe Labcorp $34.94? (Part 3)

By MATTHEW HOLT For those of you waiting for the Labcorp, Blue Shield of California, Brown & Toland Physicians Physicians update, the ball has been moved a couple of years down the field. If you want to catch up here is part 1, part 2 and part 3) You’ll recall we left it with a mystery…

Read More

‘Alternative Facts’ Aren’t a Reason To Skip Vaccines

President Donald Trump’s administrations have been notorious for an array of “alternative facts” — ranging from the relatively minor (the size of inaugural crowds) to threats to U.S. democracy, such as who really won the 2020 election. And over the past six months, the stakes have been life or death: Trump’s health officials have been…

Read More

Pharma CEOs: ‘European drug prices are too low’

At least according to CEOs from Novartis, Sanofi and AstraZeneca. Reuters reports: European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., where tariff threats have triggered a wave of pharma investment announcements. AstraZeneca Chief Executive Officer Pascal Soriot said…

Read More